BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Halozyme Therapeutics Inc.

Headquarters: San Diego, CA, United States of America
Year Founded: 1998
Status: Public
Industry Sector: HealthTechnology
CEO: Helen I. Torley, MD
Number Of Employees: 350
Enterprise Value: $7,128,190,440
PE Ratio: 17.13
Exchange/Ticker 1: NASDAQ:HALO
Exchange/Ticker 2: N/A
Latest Market Cap: $7,262,504,960